Overview NVIDIA’s (NASDAQ:NVDA) latest earnings report might have been the biggest event in the stock market this year. Smashing expectations as well as issuing...
Cash-strapped landlords with maturing property debt aren’t being scared off by 12%-16% rates of interest, said Ben Miller, CEO of Fundrise, which recently launched...
The UPST Investment Thesis Just Got A Lot More Interesting Upstart Holdings (NASDAQ:UPST) appears to have bottomed by FQ1’23, significantly aided by the recent...
By Sabela Ojea Iovance Biotherapeutics on Friday said its biologics license application for lifileucel to treat advanced skin cancer was approved by the Food...